Last reviewed · How we verify
NCT05158114
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia
Phase 1 trial testing AlloRx in Testicular Injury. Withdrawn.
3 April 2025
Quick facts
| Lead sponsor | The Foundation for Orthopaedics and Regenerative Medicine |
|---|---|
| Phase | Phase 1 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 3 April 2025 |
| Primary completion | 3 April 2025 |
| Estimated completion | 3 April 2025 |
| Sites | 1 location across Antigua and Barbuda |
Drugs / interventions tested
- AlloRx — full drug profile →
Conditions studied
- Testicular Injury — all drugs for Testicular Injury →
- Oligospermia — all drugs for Oligospermia →
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine
Who can join
Eligibility, any sex, with Testicular Injury or Oligospermia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Testicular Injury and Oligospermia
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of clinical medications on male fertility and prospects for stem cell therapy.
Mo P, Zhao Z, Ke X, Fan Y, et al · · 2023 · cited 5× · PMID 37791073 · DOI 10.3389/fcell.2023.1258574
Verify or expand the search:
- PubMed search for NCT05158114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of AlloRx
Trials testing the same drug.
- NCT05158933 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure · Phase 1 · withdrawn
- NCT06143527 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS · Phase 1 · recruiting
- NCT05152381 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis · Phase 1 · withdrawn
- NCT05147675 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA · Phase 1 · recruiting
- NCT05147766 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease · Phase 1 · terminated
Other The Foundation for Orthopaedics and Regenerative Medicine trials
Trials by the same sponsor.
- NCT05158933 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure · Phase 1 · withdrawn
- NCT07226726 — Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution · Phase 1 · recruiting
- NCT07105371 — Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution · Phase 1 · completed
- NCT06143527 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS · Phase 1 · recruiting
- NCT05152381 — Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis · Phase 1 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05158114 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Foundation for Orthopaedics and Regenerative Medicine
- Last refreshed: 6 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05158114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing